華宇藥 (6621) 月營收分析比較圖

華宇藥 (6621) 月營收報表

年度/月份	營業收入（單位：千元）				累計營業收入（單位：千元）
年度/月份	單月營收	去年同月營收	單月月增率	單月年增率	累計營收	去年累計營收	累積年增率
2025/10	6,515	7,265	0.5%	-10.3%	73,585	78,870	-6.7%
2025/09	6,482	7,475	-16.9%	-13.3%	67,070	71,605	-6.3%
2025/08	7,799	8,550	-7.9%	-8.8%	60,588	64,130	-5.5%
2025/07	8,473	8,594	4.3%	-1.4%	52,789	55,580	-5%
2025/06	8,123	7,916	25.1%	2.6%	44,316	46,986	-5.7%
2025/05	6,491	7,855	-15.4%	-17.4%	36,193	39,070	-7.4%
2025/04	7,678	7,668	9.1%	0.1%	29,702	31,215	-4.8%
2025/03	7,034	7,320	-5%	-3.9%	22,024	23,547	-6.5%
2025/02	7,402	6,660	-2.5%	11.1%	14,990	16,227	-7.6%
2025/01	7,588	9,567	8.5%	-20.7%	7,588	9,567	-20.7%
2024/12	6,992	9,606	-7.9%	-27.2%	93,454	103,222	-9.5%
2024/11	7,592	8,499	4.5%	-10.7%	86,462	93,616	-7.6%
2024/10	7,265	8,600	-2.8%	-15.5%	78,870	85,117	-7.3%
2024/09	7,475	8,036	-12.6%	-7%	71,605	76,516	-6.4%
2024/08	8,550	9,710	-0.5%	-11.9%	64,130	68,480	-6.3%
2024/07	8,594	8,118	8.6%	5.9%	55,580	58,770	-5.4%
2024/06	7,916	9,255	0.8%	-14.5%	46,986	50,652	-7.2%
2024/05	7,855	8,079	2.4%	-2.8%	39,070	41,397	-5.6%
2024/04	7,668	7,698	4.8%	-0.4%	31,215	33,318	-6.3%
2024/03	7,320	8,216	9.9%	-10.9%	23,547	25,619	-8.1%
2024/02	6,660	7,312	-30.4%	-8.9%	16,227	17,403	-6.8%
2024/01	9,567	10,091	-0.4%	-5.2%	9,567	10,091	-5.2%
2023/12	9,606	15,547	13%	-38.2%	103,222	128,107	-19.4%
2023/11	8,499	12,446	-1.2%	-31.7%	93,616	112,560	-16.8%
2023/10	8,600	11,983	7%	-28.2%	85,117	100,114	-15%
2023/09	8,036	12,182	-17.2%	-34%	76,516	88,131	-13.2%
2023/08	9,710	11,269	19.6%	-13.8%	68,480	75,948	-9.8%
2023/07	8,118	10,206	-12.3%	-20.5%	58,770	64,679	-9.1%
2023/06	9,255	8,031	14.6%	15.2%	50,652	54,473	-7%
2023/05	8,079	8,402	4.9%	-3.8%	41,397	46,442	-10.9%
2023/04	7,698	9,997	-6.3%	-23%	33,318	38,040	-12.4%
2023/03	8,216	10,322	12.4%	-20.4%	25,619	28,043	-8.6%
2023/02	7,312	7,135	-27.5%	2.5%	17,403	17,721	-1.8%
2023/01	10,091	10,586	-35.1%	-4.7%	10,091	10,586	-4.7%
2022/12	15,547	11,675	24.9%	33.2%	128,107	105,386	21.5%
2022/11	12,446	10,780	3.9%	15.4%	112,560	93,711	20.1%